Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
688.00    3.00 (0.44%)
Bid:
687.00
Ask:
690.00
Spread: 3.00 (0.437%)
Market Cap: £668.19m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Trading Update

15 Oct 2015 07:00

RNS Number : 3421C
Acal PLC
15 October 2015
 

 For Release

7.00am, 15 October 2015

 

Acal plc

First Half Trading Update

 

Acal plc (LSE: ACL, "Acal" or "the Group"), one of the leading international suppliers of customised electronics to industry, today issues a trading update for the six months ended 30 September 2015 ahead of publishing its half-year results on 30 November 2015.

 

Group reported sales for the period increased by 18% and by 30% at constant exchange rates ("CER")1, the difference reflecting the significant translational impact of Sterling strength during the period2. Like-for-like sales3 were up 2%, with gross margin higher than last financial year, and operating margin now in excess of 5%.

 

Following the acquisitions of Noratel and Foss last year, sales at CER in the Design & Manufacturing division ("D&M") have nearly doubled and like-for-like sales were up by 4%. D&M sales comprised 46% of total Group sales in the first half (up from 37% in the last financial year). Both Noratel and Foss have performed well, generating good levels of organic sales growth over their comparable pre-acquisition periods last year.

 

The Custom Distribution division (54% of total Group sales) saw sales in line with the same period last year at CER. Sales in continental Europe grew by 4% CER, with ongoing sales4 up 11% CER, whilst in the UK where the market continues to be soft, sales stabilised through the first half following last year's restructuring. As announced last year, the division discontinued sales of its final major non-specialist, low margin supplier, in line with our strategy. This decision, along with a few large, non-repeating orders last year, is expected to impact prior year comparative growth rates in the second half.

 

Cross-selling activities continue to develop positively, with further growth seen in both the cross-selling of D&M products through the Custom Distribution division, and the cross-selling of technologies to existing Custom Distribution customers.

 

 

Nick Jefferies, Group Chief Executive, commented:

 

"First half sales increased by 30% and with gross margins higher than last year, we will deliver good growth in first half earnings, as expected. Our Design & Manufacturing division and our Custom Distribution businesses in continental Europe generated good levels of organic growth for the market conditions and last year's acquisitions of Noratel and Foss are both performing well.

 

Although encouraged by some positive European macro indicators, we remain cautious over the effects of any wider economic slowdown and the continuing impact of foreign exchange translation headwinds. There are several acquisition opportunities in the pipeline and we have debt funding resources available."

For further information please contact:

Acal plc 01483 544 500

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

 

Instinctif Partners 020 7457 2020

Mark Garraway

Helen Tarbet

James Gray 

 

Notes to First Half Trading Update

1. Growth rates at constant exchange rates ("CER"). Unless stated, growth rates refer to the comparable prior year period.

 

2. The average sterling rate of exchange strengthened 12% against the Euro for the 6 months ended 30 September 2015 compared with the average rate for the first half last year (rising from €1.244 to €1.39) and strengthened 16% against Nordic currencies on average, negatively affecting reported sales for this period by around 10% and underlying operating profit by around 15%.

 

3. Like-for-like growth for the Group is calculated at CER, including the pre-acquisition periods of the Noratel Group and Foss Group which were acquired last financial year (on 17 July 2014 and 7 January 2015 respectively).

 

4. Ongoing sales exclude large, non-repeating orders from last year and sales of its final major non-specialist, low margin supplier, which was discontinued last year.

 

 

About Acal plc

 

Acal is a leading supplier of customised electronics to industry. It designs, manufactures and distributes customer-specific electronic products and solutions to 25,000 industrial manufacturers and is listed on the London Stock Exchange (LSE: ACL).

 

Acal has two divisions: Custom Distribution and Design & Manufacturing. The majority of its sales comes from products and solutions which are either created uniquely for a customer or sourced exclusively. Acal works across a range of technologies, namely Communications & Sensors, Electromechanical, Imaging & Photonics, Embedded Computers & Displays, and Power & Magnetics.

 

Acal operates through the following wholly-owned businesses: Acal BFi, Foss, Hectronic, MTC, Myrra, Noratel, RSG, Stortech and Vertec. It has operating companies and manufacturing facilities in a number of markets, including the UK, Germany, France, the Nordic region, Benelux, Italy, Poland, Slovakia and Spain, as well as in Asia (China, India, Sri Lanka and South Korea), the US and South Africa.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKPDBPBDKQKD
Date   Source Headline
11th Jun 202610:00 amRNSDirector LTIP & DSBP Awards
3rd Jun 20267:00 amRNSPreliminary results
20th May 20267:00 amRNSNotice of Full Year Results
19th May 20267:00 amRNSAcquisition of 3Gmetalworx
7th May 20261:29 pmRNSNotification of Major Holdings
17th Apr 20267:00 amRNSQ4 and full year trading update
10th Apr 20269:16 amRNSNotification of Major Holdings
27th Feb 20264:42 pmRNSNotification of Major Holdings
12th Feb 20265:18 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSQ3 Trading Update
29th Jan 20268:58 amRNSDirector/PDMR Shareholding
16th Dec 20254:00 pmRNSNotification of Major Holdings
16th Dec 20259:31 amRNSIssue of Equity & Total Voting Rights
11th Dec 20254:02 pmRNSDirector/PDMR Shareholding
4th Dec 20257:00 amRNSAcquisition of Trival
3rd Dec 20252:55 pmRNSNotification of Major Holdings
2nd Dec 20257:00 amRNSInterim Results
19th Nov 20257:15 amRNSDirector Declaration
18th Nov 20259:16 amRNSNotice of Half Year Results
28th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
16th Oct 20253:41 pmRNSNotification of Major Holdings
14th Oct 20257:00 amRNSFirst Half Trading Update
15th Sep 20252:14 pmRNSNotification of Major Holdings
4th Sep 20252:58 pmRNSNotification of Major Holdings
14th Aug 20251:27 pmRNSDirector/PDMR Shareholding
13th Aug 20258:32 amRNSDirector / PDMR Shareholding
4th Aug 20253:44 pmRNSNotification of Major Holdings
24th Jul 20252:37 pmRNSResults of Annual General Meeting
24th Jul 20257:00 amRNSTrading Update
19th Jun 202511:34 amRNSAnnual Report & Notice of AGM
18th Jun 20258:12 amRNSNotification of Major Holdings
16th Jun 20254:30 pmRNSNotification of Major Holdings
12th Jun 202510:20 amRNSDirector LTIP & DSBP Awards
4th Jun 20257:00 amRNSPreliminary results
14th May 20254:13 pmRNSNotification of Major Holdings
14th May 20252:13 pmRNSNotice of Full Year Results
16th Apr 20254:48 pmRNSNotification of Major Holdings
16th Apr 20257:00 amRNSTrading Update
9th Apr 20258:38 amRNSNotification of Major Holdings
26th Mar 20253:08 pmRNSNotification of Major Holdings
12th Mar 20258:39 amRNSDirector/PDMR Shareholdings
5th Mar 20258:05 amRNSDirector Declaration
3rd Mar 20252:20 pmRNSDirector/PDMR Shareholding
26th Feb 20254:56 pmRNSNotification of Major Holdings
18th Feb 20252:52 pmRNSNotification of Major Holdings
17th Feb 20252:37 pmRNSNotification of Major Holdings
14th Feb 20258:28 amRNSDirector / PDMR Shareholding
5th Feb 20251:08 pmRNSNotification of Major Holdings
30th Jan 20257:00 amRNSQ3 Trading Update
29th Jan 20259:40 amRNSDirector / PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.